{"Symbol": "AMGN", "AssetType": "Common Stock", "Name": "Amgen Inc", "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.", "CIK": "318154", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)", "Address": "ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "116077855000", "EBITDA": "12133000000", "PERatio": "21.24", "PEGRatio": "1.553", "BookValue": "14.54", "DividendPerShare": "6.88", "DividendYield": "0.0337", "EPS": "9.7", "RevenuePerShareTTM": "44.89", "ProfitMargin": "0.218", "OperatingMarginTTM": "0.344", "ReturnOnAssetsTTM": "0.0856", "ReturnOnEquityTTM": "0.585", "RevenueTTM": "25767000000", "GrossProfitTTM": "19265000000", "DilutedEPSTTM": "9.7", "QuarterlyEarningsGrowthYOY": "-0.035", "QuarterlyRevenueGrowthYOY": "0.044", "AnalystTargetPrice": "244.81", "TrailingPE": "21.24", "ForwardPE": "11.44", "PriceToSalesRatioTTM": "4.505", "PriceToBookRatio": "14.11", "EVToRevenue": "5.46", "EVToEBITDA": "12.73", "Beta": "0.608", "52WeekHigh": "268.39", "52WeekLow": "198.8", "50DayMovingAverage": "210.78", "200DayMovingAverage": "232.48", "SharesOutstanding": "563266000", "DividendDate": "2021-12-08", "ExDividendDate": "2021-11-15"}